COMPOSITIONS AND METHODS CONCERNING IMMUNE TOLERANCE

COVALENT POLYMER-ANTIGEN CONJUGATED PARTICLES

GLYCOTARGETING THERAPEUTICS

COMPOSITION FOR INDUCING PROLIFERATION OR ACCUMULATION OF REGULATORY T CELLS

BIODEGRADABLE POLYMERIC PARTICLES FOR DELIVERY OF POSITIVELY CHARGED THERAPEUTIC AGENTS

CD127 EXPRESSION INVERSELY CORRELATES WITH FOXP3 AND SUPPRESSIVE FUNCTION OF CD4+ TREGS

COMPOSITIONS AND METHODS FOR REDUCING THE RATE OF TYPE 1 DIABETES

T CELL EPITOPES ASSOCIATED WITH TYPE 1 DIABETES

TOLEROGENIC PEPTIDES

COMBINED DELIVERY OF ANTIGENS AND TOLEROGENIC SIGNALS VIA DUAL-SIZED HYDROGEL SPHERES AND MOF COMPOSITES FOR TYPE-1 DIABETES VACCINE DEVELOPMENT

COMPOSITIONS AND METHODS FOR ANTIGEN-SPECIFIC TOLERANCE

ANTI-ASGR1 POLYPEPTIDES AND METHODS OF USE FOR IMMUNE TOLERANCE

COMPOSITION FOR INDUCING PROLIFERATION OR ACCUMULATION OF REGULATORY T CELLS

TREATMENT OF INSECT BITE HYPERSENSITIVITY

GLATIRAMER DEPOT SYSTEMS FOR TREATING PROGRESSIVE FORMS OF MULTIPLE SCLEROSIS

CHIMERIC PROTEINS IN AUTOIMMUNITY

NOVEL PEPTIDE MIMICS AND THEIR USE

Systems For Producing Cellular Immunotherapeutics And Methods Of Use Thereof

USE OF NON-INFORMATIONALAMINO ACID CHAINS TO MODIFY THE SOLUBILITY PROPERTIES OF PEPTIDES

PEPTIDE VACCINES AGAINST INTERLEUKIN-31

VACCINE COMPOSITION FOR BREAKING SELF-TOLERANCE

mRNA VACCINES COMPRISING IL-4 AND/OR IL-13 RNA AND USES THEREOF

NOVEL COMPOSITIONS AND USES THEREOF FOR PRODUCTION OF ALLERGEN TOLERANCE

INDUCIBLE REGULATORY T-CELL GENERATION FOR HEMATOPOIETIC TRANSPLANTS

TOLERANCE-INDUCING CONSTRUCTS AND COMPOSITIONS AND THEIR USE FOR THE TREATMENT OF IMMUNE DISORDERS

Treatment and Prophylaxis of Amyloidosis

METHOD FOR INDUCING A TOLEROGENIC IMMUNE RESPONSE

T-Cell Modulatory Multimeric Polypeptides and Methods of Use Thereof

COMPOSITIONS AND METHODS FOR TREATING IMMUNOLOGICAL DYSFUNCTION

POLYMER-LIPID HYBRID NANOPARTICLES COMPRISING A LIPID AND A BLOCK COPOLYMER AS WELL AS METHODS OF MAKING AND USES THEREOF

COMPLETE TOLEROGENIC ADJUVANT AND METHODS OF USING THE SAME

IMMUNE CELL SELECTION, EXPANSION, AND USE

MHC IB-MEDIATED MYELIN-SPECIFIC IMMUNOSUPPRESSION AS A NOVEL TREATMENT FOR MULTIPLE SCLEROSIS AND MOG ANTIBODY DISEASE

CONJUGATES WITH INHIBITORY RECEPTOR LIGANDS TO INDUCE ANERGY IN INSULIN-BINDING B CELLS

MHC IB-MEDIATED ISLET-ANTIGEN-SPECIFIC IMMUNOSUPPRESSION AS A NOVEL TREATMENT FOR TYPE 1 DIABETES

MHC IB-MEDIATED AQUAPORIN 4 (AQP4)-SPECIFIC IMMUNOSUPPRESSION AS A NOVEL TREATMENT FOR NMO

MHC IB-MEDIATED ALPHA-SYNUCLEIN-SPECIFIC TOLERANCE INDUCTION AS A NOVEL TREATMENT FOR PARKINSON'S DISEASE

ANTIGEN-SPECIFIC THERAPY FOR AUTOIMMUNE DISEASES

TOLERANCE-INDUCING CONSTRUCTS AND COMPOSITION AND THEIR USE FOR THE TREATMENT OF IMMUNE DISORDERS

PROTEIN-BASED T-CELL RECEPTOR KNOCKDOWN

USE OF ANTI-PD-1 ANTIBODY IN COMBINATION WITH ANTI-CD27 ANTIBODY IN CANCER TREATMENT

DENDRITIC CELL ASGPR TARGETING IMMUNOTHERAPEUTICS FOR MULTIPLE SCLEROSIS

Self-Assembling Nanoparticles Based On Amphiphilic Peptides

COMPOSITION FOR CYTOTOXIC T CELL DEPLETION

COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF AUTOIMMUNE CONDITIONS

Immunoprotection of Therapeutic Moieties Using Enhanced Fc Regions

Cultured Thymus Tissue Transplantation Promotes Donor-Specific Tolerance to Allogeneic Solid Organ Transplants

COMPOSITIONS AND METHODS FOR TREATING IMMUNOLOGICAL DYSFUNCTION

IMMUNOSUPPRESSIVE ANTIGEN-SPECIFIC CHIMERIC ANTIGEN RECEPTOR TREG CELLS FOR PREVENTION AND/OR TREATMENT OF AUTOIMMUNE AND ALLOIMMUNE DISORDERS

ANTI-HUMAN PAPILLOMAVIRUS (HPV) ANTIGEN-BINDING PROTEINS AND METHODS OF USE THEREOF

THERAPEUTIC VACCINES FOR TREATMENT OF CHRONIC INFLAMMATORY DISEASES

ERYTHROCYTE-BINDING THERAPEUTICS

NUCLEIC ACID STRUCTURE UTILIZING SNARE

RECOMBINANT pMHC CLASS II MOLECULES

PEPTIDE CONJUGATED PARTICLES

POLYNUCLEOTIDES ENCODING INTEGRIN BETA-6 AND METHODS OF USE THEREOF

COMPOSITIONS AND METHODS FOR INDUCING IMMUNE TOLERANCE

IMMUNOGENIC PRODUCT COMPRISING IL-4 AND/OR IL-13 FOR TREATING DISORDERS ASSOCIATED WITH ABERRANT IL-4 AND/OR IL 13 EXPRESSION OR ACTIVITY

METHODS TO ALTER THE TUMOR MICROENVIRONMENT FOR EFFECTIVE CANCER IMMUNOTHERAPY

Peptide Conjugated Particles

Pharmaceutical Composition Comprising Nanoparticles for the Targeted Delivery of Antigens

TREATMENT OF PRIMARY BILIARY CHOLANGITIS (PBC) WITH TOLERIZING NANOPARTICLES

METHOD FOR PRODUCING AN ANTI-LAG-3 ANTIBODY

COMPOSITION FOR PREVENTING OR TREATING AUTOIMMUNE DISEASES

VACCINE COMPOSITIONS DEPLETING HEMATOPOIETIC GROWTH FACTORS FOR THE TREATMENT OF INFLAMMATORY DISEASES

USE OF ANTI-PD-1 ANTIBODY IN COMBINATION WITH ANTI-CD27 ANTIBODY IN CANCER TREATMENT

METHODS FOR THE PREVENTION AND TREATMENT OF SYNUCLEINOPATHIES

ENZYMATICALLY METHYLATED DNA AND METHODS OF PRODUCTION AND THERAPEUTIC USE

VACCINE COMPOSITIONS AND METHODS FOR ENHANCED ANTIGEN-SPECIFIC VACCINATION

NOVEL IMMUNOGENIC PEPTIDES

TISSUE-DIRECTED ANTIBODIES AND METHODS OF USING THE SAME

NUCLEIC ACID VECTOR COMPOSITIONS

UTILIZATION OF ANTIBODIES TO SHAPE ANTIBODY RESPONSES TO AN ANTIGEN

Immunomodulatory Therapy For Type 1 Diabetes Mellitus Autoimmunity

COMPOSITION FOR INDUCING PROLIFERATION OR ACCUMULATION OF REGULATORY T CELLS

Composition for inducing proliferation or accumulation of regulatory T cells

NANOPARTICLE COMPOSITIONS FOR SUSTAINED THERAPY

MHC CLASS II T-CELL MODULATORY MULTIMERIC POLYPEPTIDES FOR TREATING TYPE 1 DIABETES MELLITUS (T1D) AND METHODS OF USE THEREOF

NOVEL COMBINATIONS FOR ANTIGEN BASED THERAPY

NOVEL mRNA VACCINE FOR AUTOIMMUNITY

IMMUNOMODULATION FOR THE LONG TERM PREVENTION AND TREATMENT OF AUTOIMMUNE DISEASES AND FOREIGN TISSUE REJECTION

TENASCIN-C AUTOANTIGENIC EPITOPES IN RHEUMATOID ARTHRITIS

IMPROVED METHODS OF TREATMENT USING IMMUNOGENIC PEPTIDES

ERYTHROCYTE-BINDING THERAPEUTICS

METHODS OF TREATING AUTOIMMUNE DISEASE

Antigen Presenting Polypeptide Complexes and Methods of Use Thereof

Conjugates with inhibitory receptor ligands to induce anergy in insulin-binding B cells

TOLEROGENIC SYNTHETIC NANOCARRIERS FOR ALLERGY THERAPY

CO-EXPRESSION OF CONSTRUCTS AND IMMUNOINHIBITORY COMPOUNDS

METHODS AND PLATFORMS FOR PROMOTING ANTIGEN-SPECIFIC TOLERANCE IN THE TREATMENT OF TYPE 1 DIABETES AND GRAFT REJECTION AND COMPOSITIONS RELATING THERETO

VACCINE FOR THERAPEUTIC OR PROPHYLACTIC TREATMENT OF MYASTHENIA GRAVIS

ENGINEERED Fc CONSTRUCTS

TREATMENT OF LUPUS USING HUMANIZED ANTI-CXCR5 ANTIBODIES

ASSAY TO MEASURE THE POTENCY OF RECEPTOR-LIGAND INTERACTIONS IN NANOMEDICINES

THERAPEUTIC VACCINE FOR TREATMENT OF DIABETES TYPE 1 IN CHILDREN, APPLICATION OF THE CELL SORTER AND THE METHOD OF MULTIPLYING TREG CELLS TO PRODUCE THERAPEUTIC VACCINE FOR TREATMENT OF DIABETES TYPE 1

RECOMBINANT PROTEIN CAPABLE OF RESISTING MULTIPLE SCLEROSIS AND PREPARATION METHOD AND APPLICATION THEREOF

Antigen-Presenting Polypeptides with Chemical Conjugation Sites and Methods of Use Thereof

Personalized Site-Specific Immunomodulation

Antigen-Presenting Polypeptides with Chemical Conjugation Sites and Methods of Use Thereof

MODULATED IMMUNODOMINANCE THERAPY

Antigen Presenting Polypeptide Complexes Bearing TGF-Beta and Methods of Use Thereof

MICROBIAL CONSORTIUM AND USES THEREOF

Compositions and Methods For Reducing Immune Intolerance

MULTIPLE SCLEROSIS ASSOCIATED AUTOANTIGENS, AND USE THEREOF IN THERAPY AND DIAGNOSIS

TOLEROGENIC SYNTHETIC NANOCARRIERS

APPARATUS FOR DETERMINING ADMINISTRATION FORM OF A COMPOSITION OF AN ENGINEERED VIRUS-BASED NANOPARTICLE FOR A TREATMENT OF AN AUTOIMMUNE CONDITION

Peptide

MHC CLASS II T-CELL MODULATORY POLYPEPTIDES AND METHODS OF USE THEREOF

VACCINE FOR THERAPEUTIC OR PROPHYLACTIC TREATMENT OF MYASTHENIA GRAVIS

PARTICLES ENCAPSULATING FUSION PROTEINS CONTAINING LINKED EPITOPES

USE OF ITOLIZUMAB TO REDUCE PHOSPHORYLATION OF CD6

PEPTIDE CONJUGATED PARTICLES

Combinations of Modalities for the Treatment of Diabetes

MRNA THERAPEUTIC VACCINE FOR TREATMENT OF ATHEROTHROMBOSIS

IMMUNOGENIC PEPTIDES AND THEIR USE IN IMMUNE DISORDERS

METHODS OF TREATING HYPERGLYCEMIA AND SUPPRESSING ONSET OF TYPE 1 DIABETES

C-TERMINUS MODIFIED HUMAN PAPILLOMAVIRUS TYPE 6 L1 PROTEIN AND USE THEREOF

COMPOSITIONS OF EMBEDDED EPITOPE RANDOM PEPTIDES (EERP) FOR TREATMENT OF IMMUNE-MEDIATED CONDITIONS, AND METHODS OF USE

System and Method for Controlling the Humidity and Pressure in a Luminaire

VACCINE

Systems For Producing Cellular Immunotherapeutics And Methods Of Use Thereof

AAV-BASED GENE THERAPY FOR MULTIPLE SCLEROSIS

INDUCTION OF IMMUNE TOLERANCE BY USING METHOTREXATE

T CELL RECEPTOR-DEFICIENT CHIMERIC ANTIGEN RECEPTOR T-CELLS AND METHODS OF USE THEREOF

METHODS FOR TREATING AUTOIMMUNE DISEASE USING BIOCOMPATIBLE BIOABSORBABLE NANOSPHERES

MHC class II T-cell modulatory multimeric polypeptides for treating type 1 diabetes mellitus (T1D) and methods of use thereof

COVALENT POLYMER-ANTIGEN CONJUGATED PARTICLES

RNA FOR TREATMENT OF AUTOIMMUNE DISEASES

MHC CLASS II T-CELL MODULATORY MULTIMERIC POLYPEPTIDES AND METHODS OF USE THEREOF

TOLEROGENIC SYNTHETIC NANOCARRIERS TO REDUCE IMMUNE RESPONSES TO THERAPEUTIC PROTEINS

TOLEROGENIC SYNTHETIC NANOCARRIERS TO REDUCE ANTIBODY RESPONSES

MHC CLASS II T-CELL MODULATORY MULTIMERIC POLYPEPTIDES FOR TREATING TYPE 1 DIABETES MELLITUS (T1D) AND METHODS OF USE THEREOF

TOLEROGENIC SYNTHETIC NANOCARRIERS FOR ALLERGY THERAPY

COMPOSITIONS AND METHODS OF CHIMERIC AUTOANTIBODY RECEPTOR T CELLS

TARGETED EXPANSION OF QA-1-PEPTIDE-SPECIFIC REGULATORY CD8 T CELLS TO AMELIORATE ARTHRITIS

SUPPRESSION OF DIABETES USING EXOSOMES FROM STEM CELL PROGRAMMED MYELOID CELLS

METHODS FOR TREATING CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)

CD127 EXPRESSION INVERSELY CORRELATES WITH FOXP3 AND SUPPRESSIVE FUNCTION OF CD4+ TREGS

Anti-human papillomavirus (HPV) antigen-binding proteins and methods of use thereof

IMMUNOGENIC CD1D BINDING PEPTIDES

MONOCYTES INDUCING ANTIGEN-SPECIFIC TOLERANCE, ENGINEERED MONOCYTES, AND METHOD OF USE THEREOF

NANOBODY (VHH) CONJUGATES AND USES THERE OF

ANTI-PAD2 ANTIBODY FOR TREATING AND EVALUATING AUTOIMMUNE AND INFLAMMATORY DISEASES

TREATMENT OF AUTOIMMUNITY AND TRANSPLANT REJECTION THROUGH ESTABLISHMENT AND/OR PROMOTION OF TOLEROGENIC PROCESSES BY FIBROBLAST-MEDIATED REPROGRAMMING OF ANTIGEN PRESENTING CELLS

Use of Immune Suppressive Domains as Medicaments

METHODS FOR STRATIFYING DIABETES PATIENTS

IMMUNOGENIC CONJUGATE INTENDED TO INDUCE AN IMMUNE RESPONSE DIRECTED AGAINST INTERLEUKIN-6

GLYCOLIPID COMPOSITIONS AND METHODS OF USE

NOVEL METHOD

GLYCOTARGETING THERAPEUTICS

AUTOANTIGENIC PEPTIDES (CALVICIFIV), PRESENTED BY TOLEROGENIC DENTRITIC CELLS, USEFUL FOR THE PERSONALIZED TREATMENT OF RHEUMATOID ARTHRITIS

COMPOUNDS FOR THE INDUCTION OF ANTIGEN-SPECIFIC IMMUNE TOLERANCE

Carbohydrate-Modified Particles and Particulate Formulations for Modulating an Immune Response

METHODS TO ALTER THE TUMOR MICROENVIRONMENT FOR EFFECTIVE CANCER IMMUNOTHERAPY

POLYPEPTIDES COMPRISING MUTATED FORMS OF HUMAN VEGF-A WITH REARRANGEMENTS OF DISULFIDE BONDS AND COMPOSITIONS CONTAINING SAME

Transdermal patch with separated regions for delivery of immunomodulators

SECRETABLE PROTEIN INDUCED IMMUNE TOLERIZATION AND TREATMENT OF AUTOIMMUNE, ALLERGIC AND OTHER DISEASES AND DISORDERS

ASSESSING AND TREATING AUTOIMMUNE ATAXIA

BIOINFORMATIC PROCESSES FOR DETERMINATION OF PEPTIDE BINDING

METHODS OF REDUCING IMMUNOGENICITY AGAINST FACTOR VIII IN INDIVIDUALS UNDERGOING FACTOR VIII THERAPY

COMPOSITIONS AND METHODS FOR TREATING AUTOIMMUNE DISORDERS

METHODS AND COMPOSITIONS FOR SUSTAINED IMMUNOTHERAPY

POLYMERIC NANOPARTICLES THAT TARGET LIVER SINUSOIDAL ENDOTHELIAL CELLS TO INDUCE ANTIGEN-SPECIFIC IMMUNE TOLERANCE

METHOD OF DETERMINING THE IDENTITY AND/OR AMOUNT OF AN ANTI-IL-31 ANTIBODY IN A SAMPLE

DNA VACCINE CAPABLE OF EFFECTIVELY TREATING AND/OR PREVENTING TYPE 1 DIABETES AND USE THEREOF

BACTERIA-ENGINEERED TO ELICIT ANTIGEN-SPECIFIC T-CELLS

METHODS FOR PROVIDING POLYMERIC SYNTHETIC NANOCARRIERS FOR GENERATING ANTIGEN-SPECIFIC TOLERANCE IMMUNE RESPONSES

IMMUNOACTIVE MICROPARTICLES AND USES THEREOF

Cell populations having immunoregulatory activity, method for isolation and uses

MODIFIED VIRUS-LIKE PARTICLES OF CMV

VACCINE FORMULATIONS

IMMUNOGENIC PEPTIDES WITH NEW OXIDOREDUCTASE MOTIFS

PRODUCTION OF MHC II/CII COMPLEXES

Systems for producing cellular immunotherapeutics and methods of use thereof

CROSS-REACTIVE EPITOPE FOR MULTIPLE SCLEROSIS

HLA-DR/CII PEPTIDE COMPLEXES FOR TREATING ARTHRITIS

Metabolic Reprogramming of Immune Cells for the Treatment or Prevention of Diseases and Disorders

METHOD OF INDUCING ANTIGEN-SPECIFIC TOLERANCE IN A SUBJECT BY ADMINISTERING A COMPOSITION COMPRISING AN APOPTOTIC BODY SURROGATE AND COUPLED IMMUNODOMINANT ANTIGENIC EPITOPES ASSOCIATED WITH AUTOIMMUNE DISEASE

Engineered Fc constructs

TOLEROGENIC ARTIFICIAL ANTIGEN-PRESENTING CELLS

PEPTIDES AND CONJUGATES FOR TREATMENT OF ARTHRITIS

REGULATORY T CELL EPITOPES, COMPOSITIONS AND USES THEREOF

COMPOSITIONS AND METHODS FOR INDUCING IMMUNE TOLERANCE

MULTI-EPITOPIC CONSTRUCT

Therapeutics for autoimmune disease: synthetic antigens

Method and system for protecting monarch butterflies from pesticides

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR INDUCING IMMUNE TOLERANCE BY MUCOSAL VACCINATION WITH FC-COUPLED ANTIGENS

COMPOSITIONS AND METHODS FOR TREATING AUTOIMMUNE DISEASES AND CANCERS

Compositions Comprising Apoptotic Signaling and Methods for Induction of Antigen-Specific Tolerance

Antigen-Presenting Polypeptides with Chemical Conjugation Sites and Methods of Use Thereof

COMPOSITIONS AND METHODS FOR INDUCING ANTIGEN-SPECIFIC TOLERANCE

IMMUNOGENIC PEPTIDES FOR USE IN THE PREVENTION AND/OR TREATMENT OF INFECTIOUS DISEASES, AUTOIMMUNE DISEASES, IMMUNE RESPONSES TO ALLOFACTORS, ALLERGIC DISEASES, TUMORS, GRAFT REJECTION AND IMMUNE RESPONSES AGAINST VIRAL VECTORS USED FOR GENE THERAPY OR GENE VACCINATION

Vaccine

Vaccine

Method for Restoring Immune Tolerance In Vivo

PEPTIDE IMMUNOGENS TARGETING INTERLEUKIN 6 (IL-6) AND FORMULATIONS THEREOF FOR IMMUNOTHERAPY OF DISEASES IMPACTED BY IL-6 DYSREGULATION

T-CELL MODULATORY MULTIMERIC POLYPEPTIDES AND METHODS OF USE THEREOF

COMPOSITIONS AND METHODS FOR TREATING IMMUNOLOGICAL DYSFUNCTION

COMPOSITION FOR INDUCING PROLIFERATION OR ACCUMULATION OF REGULATORY T CELLS

Cultured thymus tissue transplantation promotes donor-specific tolerance to allogeneic solid organ transplants

COMPOSITIONS AND METHODS FOR METAL CONTAINING FORMULATIONS CAPABLE OF MODULATING IMMUNE RESPONSE

Dendritic cell ASGPR targeting immunotherapeutics for multiple sclerosis

ANTIGEN-SPECIFIC T CELLS FOR INDUCING IMMUNE TOLERANCE

POLYPEPTIDES AND POLYNUCLEOTIDES, AND USES THEREOF FOR TREATMENT OF IMMUNE RELATED DISORDERS AND CANCER

PERSONALISED IMMUNOGENIC PEPTIDE IDENTIFICATION PLATFORM

NANOPARTICLES FOR PREPARING REGULATORY B CELLS

IMMUNOMODULATORY PHARMACEUTICAL COMPOSITIONS INCLUDING A SYNTHETIC PEPTIDE AND TRANSFORMING GROWTH FACTOR BETA

PEPTIDE VACCINE FOR PREVENTION AND IMMUNOTHERAPY OF DEMENTIA OF THE ALZHEIMER'S TYPE

GLATIRAMER DEPOT SYSTEMS FOR TREATING PROGRESSIVE FORMS OF MULTIPLE SCLEROSIS

METHODS, DEVICE AND REAGENTS TO TREAT ALLERGY AND AUTOIMMUNE DISEASE

Methods and Compositions Relating to p62/SQSTM1 for the Treatment and Prevention of Inflammation-Associated Diseases

PEPTIDE CONJUGATED PARTICLES

Immunosuppressive antigen-specific chimeric antigen receptor Treg cells for prevention and/or treatment of autoimmune and alloimmune disorders

Anti-human papillomavirus (HPV) antigen-binding proteins and methods of use thereof

NOVEL COMBINATIONS FOR ANTIGEN BASED THERAPY

Peptide conjugated particles

IMMUNOGENIC PEPTIDES WITH IMPROVED OXIDOREDUCTASE MOTIFS

Recombinant polypeptides comprising modified MHC class II DRa1 domains and methods of use

Modified FVIII Apitope Peptides

Materials and methods for the development of an antigen-specific immune non-responsiveness state

MICROBIAL CONSORTIUM AND USES THEREOF

Assessing and treating autoimmune ataxia

THERAPEUTIC INDUCTION OF TOLERANCE USING RECOMBINANT CELL SURFACE ANTIGENS

BACTERICIDAL/PERMEABILITY INCREASING PROTEIN FOR USE IN A METHOD OF IMMUNIZATION, PREFERABLY AS AN ADJUVANT IN A METHOD OF VACCINATION

Methods and compositions for treating autoimmune and inflammatory conditions

METHODS OF USING LYSINE DEACETYLASE (KDAC) INHIBITION TO GENERATE ANTIGEN SPECIFIC MEMORY T CELL RESPONSES FOR DURABLE IMMUNOTHERAPY

TRANSFORMING GROWTH FACTOR-BETA-RESPONSIVE POLYPEPTIDES AND THEIR METHODS FOR USE

INDUCIBLE REGULATORY T-CELL GENERATION FOR HEMATOPOIETIC TRANSPLANTS

METHOD OF INDUCING IMMUNE TOLERANCE BY ADMINISTERING ACTIVE PRINCIPLE-LOADING RBC's

TARGETED EXPANSION OF QA-1-PEPTIDE-SPECIFIC REGULATORY CD8 T CELLS TO AMELIORATE ARTHRITIS

ALUMINUM BASED ADJUVANTS FOR TOLEROGENIC VACCINATION

Regulatory T cell epitopes, compositions and uses thereof

COMPOSITIONS AND METHODS CONCERNING IMMUNE TOLERANCE

Erythrocyte-binding therapeutics

METHODS FOR TREATING DISORDERS ASSOCIATED WITH ANGIOGENESIS AND NEOVASCULARIZATION

Regulatory T cell epitopes, compositions and uses thereof

METHODS AND COMPOSITIONS FOR TREATING INFLAMMATION

METHODS AND COMPOSITIONS FOR TREATING MULTIPLE SCLEROSIS AND RELATED DISORDERS

Carbohydrate-Modified Particles and Particulate Formulations for Modulating an Immune Response

Immunogenic product comprising IL-4 and/or IL-13 for treating disorders associated with aberrant IL-4 and/or IL 13 expression or activity

Immunoprotection of Therapeutic Moieties Using Enhanced Fc Regions

GABA agonists in the treatment of disorders associated with metabolic syndrome and GABA combinations in treatment or prophylaxis of type I diabetes

PHOSPHOLIPASE A2 RECEPTOR ANTIGENS AND THEIR MEDICAL USE

APOPTOTIC CELL-MEDIATED INDUCTION OF ANTIGEN SPECIFIC REGULATORY T-CELLS FOR THE THERAPY OF AUTOIMMUNE DISEASES IN ANIMALS AND HUMANS

Method and system for protecting honey bees from pesticides

COMPOSITIONS AND METHODS FOR TREATING AN INFLAMMATORY DISEASE OR DISORDER

Microparticle systems and their use for the treatment of multiple sclerosis

N-terminal epitopes in amyloid beta and conformationally-selective antibodies thereto

COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF AUTOIMMUNE CONDITIONS

Use of anti-PD-1 antibody in combination with anti-CD27 antibody in cancer treatment

INTRACELLULAR DELIVERY OF BIOMOLECULES TO INDUCE TOLERANCE

Particles for spatiotemporal release of agents

AUTOIMMUNE ANTIGENS AND CANCER

System and method for microneedle delivery of microencapsulated vaccine and bioactive proteins

MULTIPLE SCLEROSIS ASSOCIATED AUTOANTIGENS, AND USE THEREOF IN THERAPY AND DIAGNOSIS

Cyclic compound/peptide comprising an A-beta15-18 peptide and a linker that is covalently coupled to the n-terminus residue and the c-terminus residue of the A-BETA15-18 peptide

Method for inducing a tolerogenic immune response

Erythrocyte-binding therapeutics

PEPTIDE IMMUNOGENS OF IL-31 AND FORMULATIONS THEREOF FOR THE TREATMENT AND/OR PREVENTION OF ATOPIC DERMATITIS

Motile sperm domain containing protein 2 and inflammation

TREATMENT OF LUPUS USING HUMANIZED ANTI-CXCR5 ANTIBODIES

ANTIGENIC PEPTIDES DERIVING FROM SECRETOGRANIN V AND USES THEREOF FOR THE DIAGNOSIS AND TREATMENT OF TYPE 1 DIABETES

Methods and Compositions for the Treatment of Autoimmune and Inflammatory Diseases

Therapeutic pooled blood apoptotic cell preparations and uses thereof

Compositions for expanding regulatory T cells (Treg), and treating autoimmune and inflammatory diseases and conditions

Oral dissolving films containing microencapsulated vaccines and methods of making same

METHODS TO PRODUCE PEPTIDES, POLYPEPTIDES OR CELLS FOR MODULATING IMMUNITY

Treatment and Prophylaxis of Amyloidosis

Peptide Conjugated Particles

Methods and Compositions for Modulating TH-GM Cell Function

NOVEL COMPLEXES OF TYPES OF MHC CLASS II THAT BIND TO COLLAGEN TYPE II PEPTIDES AND THEIR USE ON DIAGNOSIS AND TREATMENT

CONTROLLED RELEASE FORMULATIONS FOR THE INDUCTION AND PROLIFERATION OF BLOOD CELLS

Immunogenic peptides comprising an MHC class II T cell epitope and a redox motif

Enhancing T cell activation using altered MHC-peptide ligands

METHODS OF TREATING AUTOIMMUNE DISEASE

immune modulators and uses thereof

Methods for suppressing or alleviating primary or secondary progressive multiple sclerosis (PPMS or SPMS) using sustained release glatiramer depot systems

Immunomodulatory pharmaceutical compositions including a synthetic peptide and transforming growth factor beta

NOVEL COMPOSITION AND USE THEREOF

Induction of immune tolerance by using methotrexate

Peptide conjugated particles

Protein-based T-cell receptor knockdown

Immunogenic peptides and their use in immune disorders

Peptide conjugated particles

Targeted expansion of Qa-1-peptide-specific regulatory CD8 T cells to ameliorate arthritis

Method and system for protecting honey bees from pesticides

Citrullinated peptides that bind to types of MHC class II and their use on diagnosis and treatment

COMBINATIONS OF MODALITIES FOR THE TREATMENT OF DIABETES

Method for depleting cytotoxic T cells using an anti-LAG-3 antibody composition

APOPTOTIC CELL-MEDIATED INDUCTION OF ANTIGEN SPECIFIC REGULATORY T-CELLS FOR THE THERAPY OF AUTOIMMUNE DISEASES IN ANIMALS AND HUMANS

COMPOSITIONS AND METHODS FOR AUTOIMMUNE DISEASE TREATMENT

Composition for inducing proliferation or accumulation of regulatory T cells

Compositions comprising D-amino acid peptides and methods of production and use thereof for inhibiting autoantibodies

Modified virus-like particles of CMV

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR INDUCING IMMUNE TOLERANCE BY MUCOSAL VACCINATION WITH FC-COUPLED ANTIGENS

Combination Therapy of Acellular Pro-Tolerogenic and Pro-Inflammatory Preparations for Modulating the Immune System

AAV-BASED GENE THERAPY FOR MULTIPLE SCLEROSIS

Humanized antibodies

Novel Combinations for Antigen Based Therapy

Glycotargeting therapeutics